Trial Profile
Aripiprazole in the treatment of Tourette's syndrome.
Status:
Discontinued
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 08 Oct 2011
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Gilles de la Tourette's syndrome
- Focus Therapeutic Use
- 04 Oct 2011 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 11 Dec 2006 New trial record.